Showing 1 - 20 results of 6,485 for search '(( long ((mean decrease) OR (a decrease)) ) OR ( a ((marker decrease) OR (marked decrease)) ))', query time: 0.78s Refine Results
  1. 1
  2. 2
  3. 3

    Relationship between the Gender Representation Disparity Index (GRDI) and average explicit sex markers in film criticism, illustrating a decrease in markers as the GRDI moves toward a female-dominated cast. by Jad Doughman (20636304)

    Published 2025
    “…<p>Relationship between the Gender Representation Disparity Index (GRDI) and average explicit sex markers in film criticism, illustrating a decrease in markers as the GRDI moves toward a female-dominated cast.…”
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

    Published 2025
    “…Additionally, there is an increase in plaque size mainly observed in the olfactory, hippocampal, cortical, and striatal areas. (D) Long-term treatment with a high dose of netoglitazone displays a decrease in plaque size, particularly observed in the orbital cortex, olfactory area, hippocampus, thalamus, hypothalamus, midbrain, and hindbrain regions.…”
  16. 16
  17. 17

    Real-world mepolizumab treatment in patients with severe asthma decreased exacerbations, oral corticosteroid use, and healthcare resource utilization and costs over 4 years: a retr... by Wendy C. Moore (10682686)

    Published 2025
    “…</p> <p>Among 189 eligible patients, mean asthma exacerbation rate (AER) declined progressively from baseline during follow-up: AER decreased by 53.8% at Year 1 and 73.8% by Year 4 (<i>p</i> < 0.001). …”
  18. 18
  19. 19
  20. 20